+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Needle Free Drug Delivery Device Market by Product Type, Drug Type, Application, End User, Distribution Channel, Administration Route - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968741
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The needle-free drug delivery device market is rapidly advancing, offering pioneering alternatives that align with changing healthcare priorities and patient expectations. With therapies shifting toward noninvasive administration, senior executives face new opportunities and challenges in strategic planning and competitive differentiation in this dynamic sector.

Market Snapshot: Needle-Free Drug Delivery Device Market

The global needle-free drug delivery device market grew from USD 13.70 billion in 2024 to USD 15.85 billion in 2025. Anticipated ongoing growth at a CAGR of 15.31% is set to drive the market toward USD 32.22 billion by 2030. Growing demand for self-administration, patient safety, and regulatory pressures on sharps waste reduction are key trends reshaping this landscape.

Scope & Segmentation of the Needle-Free Drug Delivery Device Market

This report delivers a comprehensive analysis by segmenting the needle-free drug delivery device market across technologies, applications, and geographies. Decision-makers can leverage this structured overview to evaluate current positioning and future expansion avenues.

  • Product Types: Includes jet injectors (gas-powered, spring-based), and microarray patches (dissolvable, hollow, solid). Each technology addresses unique clinical and operational requirements.
  • Drug Types: Focus areas include insulin (spanning basal—intermediate and long-acting, as well as bolus—rapid and short-acting therapies), and vaccines (COVID-19 mRNA and viral vector, and influenza variants such as H5N1 and seasonal subtypes).
  • Application Areas: Dermatology, diabetes management, immunization, and pain management solutions are highlighting new use cases for both institutional and self-administration modalities.
  • End Users: Key end users are ambulatory surgical centers, clinics, hospitals, and home care environments, reflecting a clear trend towards decentralized healthcare delivery.
  • Distribution Channels: Market access spans direct sales, hospital pharmacies, online pharmacies, and retail pharmacy outlets—each shaping product reach and brand engagement strategies.
  • Administration Routes: Intradermal, intramuscular, and subcutaneous delivery pathways underscore distinct device engineering requirements and flexibility across patient populations.
  • Regional Coverage: In-depth insights are provided for the Americas (USA—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Competitor Profiling: The analysis covers leading companies such as PharmaJet, Antares Pharma, West Pharmaceutical Services, Nitto Denko, Haselmeier, Nemera, Kindeva Drug Delivery, Vaxxas, Bioject Medical Technologies, and Zosano Pharma Corporation.

Key Takeaways for Decision-Makers

  • Adoption of needle-free devices is being driven by patient demand for pain-free solutions and by institutional needs to improve workflow efficiency.
  • Strategic partnerships among device manufacturers, pharmaceutical firms, and material innovators are accelerating the clinical development and scale-up of next-generation platforms.
  • Integration of digital health features, such as device-to-cloud connectivity and sensor-based adherence tracking, is rapidly becoming a standard expectation in procurement and product lifecycle planning.
  • Operational agility is essential, as localized manufacturing and supply-chain resilience strategies are now key responses to external pressures and regulatory developments.
  • Regulatory alignment, particularly in key markets such as the United States, Europe, and Asia-Pacific, is lowering market entry barriers and fostering the growth of decentralized self-administration models.

Tariff Impact on Supply Chains

The 2025 introduction of U.S. tariffs on imported medical device components has prompted manufacturers to diversify suppliers and regionalize production. This transition to localized facilities is enhancing supply resilience and increasing competitiveness, while collaborative R&D efforts focus on domestic development of advanced materials. Price transparency now features more prominently in procurement, supporting sustained market access despite shifting cost structures.

Methodology & Data Sources

The report’s findings are underpinned by a rigorous, three-phase research approach. Thorough secondary analysis established a foundational knowledge base, covering peer-reviewed studies, regulatory data, and industry filings. Extensive primary interviews with engineers and clinicians provided real-world context and reliability, while structured triangulation ensured robust, multi-layered insights. All quantitative projections are cross-verified for consistency.

Why This Report Matters

  • Enables executives to benchmark product portfolios, procurement strategies, and partnership models against evolving best practices in noninvasive drug delivery.
  • Offers actionable insights into patient-centered innovation, digital integration, and supply chain adaptation, empowering confident, data-led strategic planning.
  • Assists stakeholders in aligning investments and go-to-market strategies with segment growth drivers and regional demand variations.

Conclusion

Market adoption of needle-free drug delivery technologies is shaping new standards for patient experience and operational flexibility. The combination of collaboration, regulatory support, and innovation signals continued momentum in this evolving field. Senior leaders can leverage these insights to position their organizations for sustainable growth and industry relevance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Needle Free Drug Delivery Device Market, by Product Type
8.1. Introduction
8.2. Jet Injector
8.2.1. Gas Powered
8.2.2. Spring Based
8.3. Microarray Patch
8.3.1. Dissolvable Microarray
8.3.2. Hollow Microarray
8.3.3. Solid Microarray
9. Needle Free Drug Delivery Device Market, by Drug Type
9.1. Introduction
9.2. Insulin
9.2.1. Basal Insulin
9.2.1.1. Intermediate Acting Insulin
9.2.1.2. Long Acting Insulin
9.2.2. Bolus Insulin
9.2.2.1. Rapid Acting Insulin
9.2.2.2. Short Acting Insulin
9.3. Vaccines
9.3.1. COVID-19 Vaccine
9.3.1.1. Mrna Vaccine
9.3.1.2. Viral Vector Vaccine
9.3.2. Influenza Vaccine
9.3.2.1. H5N1 Influenza
9.3.2.2. Seasonal Influenza
10. Needle Free Drug Delivery Device Market, by Application
10.1. Introduction
10.2. Dermatology
10.3. Diabetes Management
10.4. Immunization
10.5. Pain Management
11. Needle Free Drug Delivery Device Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Home Care Settings
11.5. Hospitals
12. Needle Free Drug Delivery Device Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Hospital Pharmacies
12.4. Online Pharmacies
12.5. Retail Pharmacies
13. Needle Free Drug Delivery Device Market, by Administration Route
13.1. Introduction
13.2. Intradermal
13.3. Intramuscular
13.4. Subcutaneous
14. Americas Needle Free Drug Delivery Device Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Needle Free Drug Delivery Device Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Needle Free Drug Delivery Device Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. PharmaJet, Inc.
17.3.2. Antares Pharma, Inc.
17.3.3. West Pharmaceutical Services, Inc.
17.3.4. Nitto Denko Corporation
17.3.5. Haselmeier GmbH
17.3.6. Nemera S.A.
17.3.7. Kindeva Drug Delivery LLC
17.3.8. Vaxxas Pty Ltd
17.3.9. Bioject Medical Technologies, Inc.
17.3.10. Zosano Pharma Corporation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. NEEDLE FREE DRUG DELIVERY DEVICE MARKET MULTI-CURRENCY
FIGURE 2. NEEDLE FREE DRUG DELIVERY DEVICE MARKET MULTI-LANGUAGE
FIGURE 3. NEEDLE FREE DRUG DELIVERY DEVICE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. NEEDLE FREE DRUG DELIVERY DEVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. NEEDLE FREE DRUG DELIVERY DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NEEDLE FREE DRUG DELIVERY DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY GAS POWERED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY SPRING BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISSOLVABLE MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY HOLLOW MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY SOLID MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INTERMEDIATE ACTING INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY LONG ACTING INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY RAPID ACTING INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY SHORT ACTING INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MRNA VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VIRAL VECTOR VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY H5N1 INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY SEASONAL INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY IMMUNIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INTRADERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 86. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 88. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 89. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 90. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 91. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 92. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 93. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 94. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 95. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 96. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. CANADA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 100. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 102. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 103. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 104. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 105. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 106. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 107. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 108. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 110. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. MEXICO NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 171. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 173. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 174. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 175. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 176. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 177. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 178. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 179. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 180. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 181. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. GERMANY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 185. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 187. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 188. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 189. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 190. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 191. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 192. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 193. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 194. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 195. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. FRANCE NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 213. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 215. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 216. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 217. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 218. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 219. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 220. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 221. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 222. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 223. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. ITALY NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 227. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 229. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 230. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 231. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 232. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 233. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 234. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 235. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 236. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 237. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. SPAIN NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 241. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 255. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 257. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 258. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 259. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 260. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 262. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 269. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 271. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 272. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 273. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 283. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY JET INJECTOR, 2018-2030 (USD MILLION)
TABLE 285. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY MICROARRAY PATCH, 2018-2030 (USD MILLION)
TABLE 286. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 287. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INSULIN, 2018-2030 (USD MILLION)
TABLE 288. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BASAL INSULIN, 2018-2030 (USD MILLION)
TABLE 289. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY BOLUS INSULIN, 2018-2030 (USD MILLION)
TABLE 290. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 291. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY COVID-19 VACCINE, 2018-2030 (USD MILLION)
TABLE 292. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY INFLUENZA VACCINE, 2018-2030 (USD MILLION)
TABLE 293. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. DENMARK NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2030 (USD MILLION)
TABLE 297. NETHERLANDS NEEDLE FREE DRUG DELIVERY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. NETHERLANDS NEEDLE FREE DRUG DELIVERY DEVICE MA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Needle Free Drug Delivery Device market report include:
  • PharmaJet, Inc.
  • Antares Pharma, Inc.
  • West Pharmaceutical Services, Inc.
  • Nitto Denko Corporation
  • Haselmeier GmbH
  • Nemera S.A.
  • Kindeva Drug Delivery LLC
  • Vaxxas Pty Ltd
  • Bioject Medical Technologies, Inc.
  • Zosano Pharma Corporation

Table Information